Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hak Choy

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 15, 2004
IntroductionHak Choy
Oncology (Williston Park, N.Y.)|September 2, 2004
Chemoradiation in NSCLC: focus on the role of gemcitabineHak Choy
Expert Review of Anticancer Therapy|July 13, 2006
Satraplatin: an orally available platinum analog for the treatment of cancerHak Choy
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
RTOG current clinical trials in lung cancer. OverviewHak Choy
Progress in Experimental Tumor Research|June 11, 2003
Potential for combined modality therapy of cyclooxygenase inhibitors and radiationDebabrata Saha, Hak Choy
Current Oncology Reports|June 5, 2003
Concurrent chemoradiotherapy for inoperable stage III non-small-cell lung cancerRobert MacRae, Hak Choy
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 19, 2011
Summary of presentations from the 11th targeted therapies for lung cancer meeting: radiation oncologyPuneeth Iyengar, Hak Choy
Journal of the National Cancer Institute|October 2, 2003
Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rational advance?Hak Choy, Luka Milas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2016
Improving Treatment Options for Brain Metastases From ALK-Positive Non-Small-Cell Lung CancerZabi Wardak, Hak Choy
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 28, 2017
Single-Fraction Carbon Ion Radiotherapy for Early-Stage NSCLC-The Future Is NowAaron Laine, Hak Choy
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
International Journal of Radiation Oncology, Biology, Physics|May 15, 2004
IntroductionHak Choy
Oncology (Williston Park, N.Y.)|September 2, 2004
Chemoradiation in NSCLC: focus on the role of gemcitabineHak Choy
Expert Review of Anticancer Therapy|July 13, 2006
Satraplatin: an orally available platinum analog for the treatment of cancerHak Choy
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
RTOG current clinical trials in lung cancer. OverviewHak Choy
Progress in Experimental Tumor Research|June 11, 2003
Potential for combined modality therapy of cyclooxygenase inhibitors and radiationDebabrata Saha, Hak Choy
Current Oncology Reports|June 5, 2003
Concurrent chemoradiotherapy for inoperable stage III non-small-cell lung cancerRobert MacRae, Hak Choy
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 19, 2011
Summary of presentations from the 11th targeted therapies for lung cancer meeting: radiation oncologyPuneeth Iyengar, Hak Choy
Journal of the National Cancer Institute|October 2, 2003
Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rational advance?Hak Choy, Luka Milas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2016
Improving Treatment Options for Brain Metastases From ALK-Positive Non-Small-Cell Lung CancerZabi Wardak, Hak Choy
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 28, 2017
Single-Fraction Carbon Ion Radiotherapy for Early-Stage NSCLC-The Future Is NowAaron Laine, Hak Choy
Pageof 14